Brimonidine-Soluplus Nanomicelles: Preparation and in-vitro evaluation
DOI:
https://doi.org/10.31351/vol34iss1pp246-255Keywords:
Brimonidine, Nanomicelle, Ophthalmic, Soluplus, Thin-film hydrationAbstract
Brimonidine is an active pharmaceutical ingredient used to treat glaucoma as a topical eye drop. Ophthalmic topical preparations are associated with low ocular bioavailability due to several physiological and analytical barriers. Many approaches have been investigated to overcome this problem, for example, changing the dosage form by using ocular injections, altering the chemical formula of the medicines as a prodrug, or using different drug carrier systems like nanomaterials. This study aims to prepare nanomicelles as an ophthalmic drug carrier for topical application by using Soluplus® as a polymeric surfactant and enhancing their physical properties by studying different factors. Brimonidine–soluplus nanomicelles were prepared by two methods, thin film hydration and direct dissolution. The physical properties of the prepared nanomicelles were analyzed using two factors, including brimonidine concentration and the ratio of polymer to brimonidine concentration regarding their effect on particle size and entrapment efficiency using Zetasizer and amicon® ultra centrifugal filter units 10 KDa MWCO, respectively. The selected best formula had been characterized by Differential Scanning Calorimetry (DSC), Fourier transform infrared (FTIR), Field Emission Scanning Electron Microscope (FESEM), and in-vitro release pattern compared with free aqueous brimonidine suspension. Results showed that Soluplus® nanomicelle increases the intrinsic solubility of brimonidine compared to free form in water as an aqueous suspension by 2.17 folds for the selected best formula. However, there was a highly significant effect of soluplus® and brimonidine concentrations on the physical appearance and percentage entrapment efficiency of the prepared nanomicelles and non on the polydispersity index. Furthermore, soluplus® concentration had a highly significant effect on the particle size, whereas brimonidine concentration did not. The method of nanomicelle preparation had a highly significant effect on the nanomicelle's physical appearance and percentage entrapment efficiency, in which the thin film was the best. The selected best formula contains 1.98 mg/ml brimonidine with 59.4 mg/ml soluplus had a particle size of (75.75± 1.13nm), polydispersity index of (0.1243±0.02) and percentage entrapment efficiency (53.49±0.58 %) prepared by thin-film hydration method and had a rapid in-vitro release rate (65.52%±0.26) within 15 minutes compared to aqueous brimonidine suspension (23.88%±0.08). DSC, FTIR, and FESEM confirmed the formation of the brimonidine-soluplus-loaded nanomicelles. This study concludes the effectiveness of using a polymeric surfactant to prepare nanomicelles for brimonidine with enhanced physicochemical properties as an ophthalmic drug carrier system.
How to Cite
Publication Dates
Received
Revised
Accepted
Published Online First
References
Oh DJ, Chen JL, Vajaranant TS, Dikopf MS. Brimonidine tartrate for the treatment of glaucoma. Expert opinion on pharmacotherapy. 2019 Jan 2;20(1):115-22.
PubChem [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2004-. PubChem Compound Summary for CID 2435, Brimonidine; [cited 2024 Mar. 22]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Brimonidine
Reardon G, Kotak S, Schwartz GF. Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review. Patient preference and adherence. 2011 Sep 23:441-63.
Rahić O, Tucak A, Omerović N, Sirbubalo M, Hindija L, Hadžiabdić J, Vranić E. Novel drug delivery systems fighting glaucoma: Formulation obstacles and solutions. Pharmaceutics. 2020 Dec 26;13(1):28.
Al Gawhari FJ. Factors affecting on in vitro release of miconazole from in situ ocular gel. J Adv Pharm Technol Res. 2023 Oct-Dec;14(4):294-298. doi: 10.4103/japtr.japtr_91_23. Epub 2023 Oct 30. PMID: 38107457; PMCID: PMC10723164.
Bachu RD, Chowdhury P, Al-Saedi ZHF, Karla PK, Boddu SHS. Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases. Pharmaceutics. 2018 Feb 27;10(1):28. doi: 10.3390/pharmaceutics10010028. PMID: 29495528; PMCID: PMC5874841.
Nayak K, Misra M. A review on recent drug delivery systems for posterior segment of eye. Biomedicine & pharmacotherapy. 2018 Nov 1;107:1564-82.
Jiang S, Franco YL, Zhou Y, Chen J. Nanotechnology in retinal drug delivery. International journal of ophthalmology. 2018;11(6):1038.
Yang C, Yang J, Lu A, Gong J, Yang Y, Lin X, Li M, Xu H. Nanoparticles in ocular applications and their potential toxicity. Frontiers in molecular biosciences. 2022 Jul 15;9:931759.
Salih, Zainab Thabit and Fatima J Al-Gawhari. “Improvement of Entrapment and Ocular Permeability of Ganciclovir Nanostructured Lipid Carriers Using Various Conditions of Preparations.” INTERNATIONAL JOURNAL OF DRUG DELIVERY TECHNOLOGY (2023): n. pag.
Srinivasarao DA, Lohiya G, Katti DS. Fundamentals, challenges, and nanomedicine‐based solutions for ocular diseases. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 2019 Jul;11(4):e1548.
Bose A, Roy Burman D, Sikdar B, Patra P. Nanomicelles: Types, properties and applications in drug delivery. IET nanobiotechnology. 2021 Feb;15(1):19-27.
Gote V, Ansong M, Pal D. Prodrugs and nanomicelles to overcome ocular barriers for drug penetration. Expert Opinion on Drug Metabolism & Toxicology. 2020 Oct 2;16(10):885-906.
Pignatello R, Corsaro R, Bonaccorso A, Zingale E, Carbone C, Musumeci T. Soluplus® polymeric nanomicelles improve solubility of BCS-class II drugs. Drug Delivery and Translational Research. 2022 Aug;12(8):1991-2006.
Abdulqader AA, Rajab NA. Preparation and characterization of Posaconazole as a Nano-micelles using d-α-Tocopheryl polyethylene glycol 1000 succinate (TPGS).
Richter A, Olbrich C, Krause M, Kissel T. Solubilization of sagopilone, a poorly water-soluble anticancer drug, using polymeric micelles for parenteral delivery. Int J Pharm. 2010 Apr 15;389(1-2):244-53. doi: 10.1016/j.ijpharm.2010.01.032. Epub 2010 Jan 25. PMID: 20100557.
Bu X, Ji N, Dai L, Dong X, Chen M, Xiong L, Sun Q. Self-assembled micelles based on amphiphilic biopolymers for delivery of functional ingredients. Trends in Food Science & Technology. 2021 Aug 1;114:386-98.
JABER SH, RAJAB NA. LASMIDITAN NANOEMULSION BASED IN SITU GEL INTRANASAL DOSAGE FORM: FORMULATION, CHARACTERIZATION AND IN VIVO STUDY. Farmacia. 2023 Nov 1;71(6).
Ali SK, Al-Akkam EJ. Bilosomes as Soft Nanovesicular Carriers for Ropinirole Hydrochloride: Preparation and In-vitro Characterization. Iraqi Journal of Pharmaceutical Sciences (P-ISSN 1683-3597 E-ISSN 2521-3512). 2023 Nov 3;32(Suppl.):177-87.
SALIH O, MUHAMMED E. Preparation, Evaluation, and Histopathological Studies of Ondansetron-Loaded Invasomes Transdermal Gel. Journal of Research in Pharmacy. 2024 Jan 1;28(1).
Hamed SB, Abd Alhammid SN. Formulation and characterization of felodipine as an oral nanoemulsions. Iraqi Journal of Pharmaceutical Sciences (P-ISSN 1683-3597 E-ISSN 2521-3512). 2021 Jun 15;30(1):209-17.
Al-lami MS, Oudah MH, Rahi FA. Preparation and characterization of domperidone nanoparticles for dissolution improvement. Iraqi Journal of Pharmaceutical Sciences (P-ISSN 1683-3597 E-ISSN 2521-3512). 2018 Jun 3;27(1):39-52.
Abdel Azim EA, Elkheshen SA, Hathout RM, Fouly MA, El Hoffy NM. Augmented in vitro and in vivo profiles of brimonidine tartrate using gelatinized-core liposomes. International journal of nanomedicine. 2022 Jun 25:2753-76.
Ponnusamy C, Sugumaran A, Krishnaswami V, Palanichamy R, Velayutham R, Natesan S. Development and evaluation of polyvinylpyrrolidone K90 and poloxamer 407 self-assembled nanomicelles: Enhanced topical ocular delivery of artemisinin. Polymers. 2021 Sep 8;13(18):3038.
Khan FU, Nasir F, Iqbal Z, Neau S, Khan I, Hassan M, Iqbal M, Ullah A, Khan SI, Sakhi M. Improved ocular bioavailability of moxifloxacin HCl using PLGA nanoparticles: Fabrication, characterization, in-vitro and in-vivo evaluation. Iranian Journal of Pharmaceutical Research: IJPR. 2021;20(3):592.
Hadi BM, Al-Khedairy EB. Preparation and Characterization of Atorvastatin Calcium Trihydrate-cyclodextrin Inclusion Complex. International Journal of Drug Delivery Technology. 2022;12(3):1171-9.
Alhagiesa AW, Ghareeb MM. The Formulation and Characterization of Nimodipine Nanoparticles for the Enhancement of solubility and dissolution rate. Iraqi Journal of Pharmaceutical Sciences (P-ISSN 1683-3597 E-ISSN 2521-3512). 2021 Dec 11;30(2):143-52.
Shamma RN, Basha M. Soluplus®: a novel polymeric solubilizer for optimization of carvedilol solid dispersions: formulation design and effect of method of preparation. Powder technology. 2013 Mar 1;237:406-14.
Bruer JD. Determining Particle Size of Polymeric Micelles in Thermothickening Aqueous Solutions.
Parra A, Jarak I, Santos A, Veiga F, Figueiras A. Polymeric micelles: A promising pathway for dermal drug delivery. Materials. 2021 Nov 28;14(23):7278.
Ai X, Zhong L, Niu H, He Z. Thin-film hydration preparation method and stability test of DOX-loaded disulfide-linked polyethylene glycol 5000-lysine-di-tocopherol succinate nanomicelles. asian journal of pharmaceutical sciences. 2014 Oct 1;9(5):244-50.
Zhou Y, Wang C, Liu W, Yang M, Xu B, Chen Y. Fast in vitro release and in vivo absorption of an anti-schizophrenic drug paliperidone from Its Soluplus®/TPGS mixed micelles. Pharmaceutics. 2022 Apr 19;14(5):889.
Ahmed L, Atif R, Eldeen TS, Yahya I, Omara A, Eltayeb M. Study the using of nanoparticles as drug delivery system based on mathematical models for controlled release. IJLTEMAS. 2019;8:52-6.
Lavra ZM, Pereira de Santana D, Ré MI. Solubility and dissolution performances of spray-dried solid dispersion of Efavirenz in Soluplus. Drug development and industrial pharmacy. 2017 Jan 2;43(1):42-54.
Caron V, Hu Y, Tajber L, Erxleben A, Corrigan OI, McArdle P, Healy AM. Amorphous solid dispersions of sulfonamide/Soluplus® and sulfonamide/PVP prepared by ball milling. Aaps Pharmscitech. 2013 Mar;14:464-74.
Rodríguez-García MM, Bayón R, Rojas E. Stability of D-mannitol upon melting/freezing cycles under controlled inert atmosphere. Energy Procedia. 2016 Jun 1;91:218-25.
https://www.echemi.com/products/pd180727138204-brimonidine.html
Yu L, Milton N, Groleau EG, Mishra DS, Vansickle RE. Existence of a mannitol hydrate during freeze‐drying and practical implications. Journal of pharmaceutical sciences. 1999 Feb 1;88(2):196-8.
Zhao Y, Huang C, Zhang Z, Hong J, Xu J, Sun X, Sun J. Sustained release of brimonidine from BRI@ SR@ TPU implant for treatment of glaucoma. Drug Delivery. 2022 Dec 31;29(1):613-23.
Alwan RM, Rajab NA. Nanosuspensions of selexipag: formulation, characterization, and in vitro evaluation. Iraqi Journal of Pharmaceutical Sciences (P-ISSN 1683-3597 E-ISSN 2521-3512). 2021 Jun 15;30(1):144-53.
Negut I, Bita B. Polymeric micellar systems—A special emphasis on “smart” drug delivery. Pharmaceutics. 2023 Mar;15(3):976.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Iraqi Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
